These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17546053)

  • 1. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
    Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP
    Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
    Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nucleophosmin in acute myeloid leukemia.
    Meani N; Alcalay M
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors.
    Horiguchi M; Koyanagi S; Okamoto A; Suzuki SO; Matsunaga N; Ohdo S
    Cancer Res; 2012 Jan; 72(2):395-401. PubMed ID: 22102693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
    Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
    Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
    Quentmeier H; Martelli MP; Dirks WG; Bolli N; Liso A; Macleod RA; Nicoletti I; Mannucci R; Pucciarini A; Bigerna B; Martelli MF; Mecucci C; Drexler HG; Falini B
    Leukemia; 2005 Oct; 19(10):1760-7. PubMed ID: 16079892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
    Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
    Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
    Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nucleophosmin in embryonic development and tumorigenesis.
    Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP
    Nature; 2005 Sep; 437(7055):147-53. PubMed ID: 16007073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
    Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
    Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
    Falini B; Mecucci C; Saglio G; Lo Coco F; Diverio D; Brown P; Pane F; Mancini M; Martelli MP; Pileri S; Haferlach T; Haferlach C; Schnittger S
    Haematologica; 2008 Mar; 93(3):439-42. PubMed ID: 18268276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
    Bartkova J; Rezaei N; Liontos M; Karakaidos P; Kletsas D; Issaeva N; Vassiliou LV; Kolettas E; Niforou K; Zoumpourlis VC; Takaoka M; Nakagawa H; Tort F; Fugger K; Johansson F; Sehested M; Andersen CL; Dyrskjot L; Ørntoft T; Lukas J; Kittas C; Helleday T; Halazonetis TD; Bartek J; Gorgoulis VG
    Nature; 2006 Nov; 444(7119):633-7. PubMed ID: 17136093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.